Section of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Institute for Health Research and Policy, School of Public Health, University of Illinois at Chicago, Chicago, Illinois.
Cancer. 2018 Sep 15;124(18):3733-3741. doi: 10.1002/cncr.31635. Epub 2018 Oct 15.
The US Preventive Services Task Force (USPSTF) endorses routine screening for genetic risk of breast and/or ovarian cancer as a component of primary health care. Implementation of this recommendation may prove challenging, especially in clinics serving disadvantaged communities.
The authors tested the feasibility of implementing the USPSTF mandate at a federally qualified health center (FQHC) to identify women who were eligible for genetic counseling (GC). A 12-month usual-care phase was followed by a 12-month intervention phase, during which time cancer genetic risk assessment (CGRA) was systematically performed for all women aged 25 to 69 years who presented for an annual examination. Women who were eligible for GC were recruited to participate in the study.
After initiating CGRA, 112 women who were eligible for GC consented to study participation, and 56% of them received a referral for GC from their primary care physician. A subgroup of 50 participants were seen by the same primary care physician during both the usual-care and intervention phases. None of these patients was referred for GC during usual care, compared with 64% after the initiation of CGRA (P < .001). Only 16% of referred participants attended a GC session.
Implementing USPSTF recommendations for CGRA as a standard component of primary health care in FQHCs is feasible and improves referral of minority women for GC, but more work is needed to understand the beliefs and barriers that prevent many underserved women from accessing cancer genetic services.
美国预防服务工作组(USPSTF)支持将乳腺癌和/或卵巢癌遗传风险的常规筛查作为初级保健的一个组成部分。实施这一建议可能具有挑战性,尤其是在为弱势社区服务的诊所中。
作者在一家合格的联邦健康中心(FQHC)测试了实施 USPSTF 授权以识别有资格接受遗传咨询(GC)的女性的可行性。在进行了为期 12 个月的常规护理阶段后,进行了为期 12 个月的干预阶段,在此期间,对所有年龄在 25 至 69 岁之间前来进行年度检查的女性进行了癌症遗传风险评估(CGRA)。有资格接受 GC 的女性被招募参加研究。
在开始 CGRA 后,有 112 名有资格接受 GC 的女性同意参与研究,其中 56%的人从他们的初级保健医生那里获得了 GC 的转介。50 名参与者的一个亚组在常规护理和干预阶段都由同一位初级保健医生就诊。与 CGRA 启动后的 64%相比,这些患者中没有一人在常规护理期间被转介接受 GC(P < 0.001)。只有 16%的被转介者参加了 GC 会议。
在 FQHC 中将 USPSTF 关于 CGRA 的建议作为初级保健的标准组成部分实施是可行的,可以增加少数族裔女性接受 GC 的转介,但需要进一步研究来了解阻止许多服务不足的女性获得癌症遗传服务的信念和障碍。